AMLX   $4.77  21.68% Market Closed After Close 4.77 0.0

Amylyx Pharmaceuticals Inc
Total Cash 309.81M
totalCashPerShare 4.551
EBITDA -176.64M
Total Debt 3.14M
quickRatio 4.481
currentRatio 4.662
Total Revenue 298.76M
debtToEquity 1.202
Revenue/Share 4.412
ROA -0.28279
ROE -0.5122
grossProfits
freeCashflow -12.66M
operatingCashflow -58.69M
earningsGrowth
revenueGrowth
grossMargins 0.085200004
ebitdaMargins -0.59123003
operatingMargins 74.57087
profitMargins -0.55519
enterpriseValue -27.87M
forwardPE -2.1361256
floatShares 46.46M
sharesOutstanding 68.08M
sharesShort 1.28M
sharesShortPriorMonth 1.49M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.87%
Short Ratio help_outline 0.97%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 3.838
Price To Book help_outline 1.06
earningsQuarterlyGrowth
netIncomeToCommon -165.87M
trailingEps -2.46%
forwardEps -1.91%
enterpriseToEbitda 0.16
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.71 3Q 2024
institutionsCount 167
lastUpdated Oct. 17, 2024, 4:04 a.m.